Presentation

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Presenter: Michael Maeng

September 23, 2018

REGISTER for free or LOG IN to view this content

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Coronary

Presentation

TCT 2018

DES/BRS/DCB

Up Next

Presentation

Endovascular Aortic Repairs: Historical Perspectives

Presenter: Darren B Schneider

September 23, 2018

More slides +

Presentation

Clinical Impact of Valve Thrombosis After TAVR

Presenter: Martina Kelly Speight

September 23, 2018

Presentation

LEADERS FREE II: Summary and Clinical Implications

Presenter: Mitchell W. Krucoff

September 23, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.